Compliance with Health and Safety Laws. To the knowledge of Seller, Seller is in compliance with all laws, governmental standards, rules and regulations applicable to Seller or to any of the Assets including, but not limited to, the Americans with Disabilities Act and similar state laws, occupational health and safety laws, and environmental laws.
Compliance with Health and Safety Laws. Throughout the term of the Charter and this Agreement, the Charter School and all employees to which each law applies shall comply with the following legal provisions. The Charter School shall maintain a written policy or administrative regulation regarding each legal provision, below, provide the District with a copy of such policy or administrative regulation, and provide the District with a copy if amended.
Compliance with Health and Safety Laws. Except as otherwise disclosed on Part N of the Disclosure Package, to Ferro's knowledge, the Subsidiary is in compliance with all Health and Safety Laws applicable to the Subsidiary the noncompliance with which is likely to have a materially adverse effect on the Powder Coatings Business Condition.
Compliance with Health and Safety Laws. PUREBASE is in compliance with all health and safety laws applicable to its business.
Compliance with Health and Safety Laws. Sxxxxx Resource is in compliance with all health and safety laws applicable to its business.
Compliance with Health and Safety Laws. Except as otherwise disclosed on Part N of the Disclosure Disc, to the Ferro Sellers’ knowledge, in the Ferro Sellers’ conduct of the Specialty Plastics Business, the Specialty Plastics Business is in compliance with all Health and Safety Laws applicable to the Specialty Plastics Business the noncompliance with which is not likely to have a material adverse effect on the Specialty Plastics Business Condition.
Compliance with Health and Safety Laws. Except as otherwise disclosed on Part N of the Disclosure Schedule and other than with regard to P.R.C. Environmental Laws or Environmental Laws, which shall be exclusively handled in Part (M) hereof, (1) the Fine Chemicals Business is in compliance with, and since January 1, 2005 has been conducted in compliance with, all Health and Safety Laws and P.R.C. Safety Laws, as applicable; and (2) neither Ferro nor Ferro Suzhou have received any written notice of any violations with respect to Health and Safety Laws applicable to the Fine Chemicals Business or P.R.C. Safety Laws, as applicable; and (3) Ferro and Ferro Suzhou have obtained all Permits required under Health and Safety Laws and P.R.C. Safety Laws, as applicable, for its respective current operation of the Fine Chemicals Business, and the Fine Chemicals Business is, and has since January 1, 2005 been, in compliance with the terms and conditions of all such Permits, respectively, and there is no suspension or cancellation of any such Permits pending, or to Ferro’s knowledge threatened.
Compliance with Health and Safety Laws. Except as otherwise disclosed on Part N of the Disclosure Package, to the Ferro Sellers' knowledge, in their conduct of the Powder Coatings Business, the Ferro Sellers are in compliance with all Health and Safety Laws applicable to the Powder Coatings Business the noncompliance with which is likely to have a materially adverse effect on the Powder Coatings Business Condition.
Compliance with Health and Safety Laws. Except as otherwise disclosed on Part N of the Disclosure Package, the conduct of the Powder Coatings Business is in material compliance with all Health and Safety Laws applicable to the Powder Coatings Business.
Compliance with Health and Safety Laws. Neither the Company nor any Subsidiary nor any Related Entity nor, to the knowledge of the Company, any Investment Entity, has received any inspection report, notice of adverse finding, warning letter, untitled letter or other correspondence with or notice from Health Canada or any other federal, provincial, territorial, state, municipal, local or foreign governmental or regulatory authority or court or arbitrator in Canada or any other country, alleging or asserting noncompliance with any applicable laws or regulations, including, without limitation, the Cannabis Act R.S.C., c. 16, the Food and Drugs Act R.S.C. 1985, c. F-27 or the Controlled Drugs and Substances Act S.C. 1996, c. 19 or any provincial cannabis-related Act or Regulation, that has not been resolved by the Company, any Subsidiary, any Related Entity or any Investment Entity, as the case may be, or that otherwise would, singularly or in the aggregate, have a Material Adverse Effect. The Company, each Subsidiary, each Related Entity, any person acting on behalf of the Company, each Subsidiary and each Related Entity and, to the knowledge of the Company, each Investment Entity and any person acting on behalf of each Investment Entity, are and have been in material compliance with applicable health care, cannabis, privacy and personal health information laws and the regulations promulgated pursuant to such laws and all other federal, provincial, territorial, state, municipal, local or foreign laws, manual provisions, policies and administrative guidance relating to the regulation of the Company in Canada or any other country. Except as disclosed in the Pricing Prospectuses and the Prospectuses, neither the Company nor any Subsidiary nor any Related Entity nor, to the knowledge of the Company, any Investment Entity, has, either voluntarily or involuntarily, initiated, conducted or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post- sale warning or other notice or action relating to the alleged safety or efficacy of any product or any alleged product defect or violation and there is no basis for any such notice or action.
